Published Date: 02 Mar 2023
Although further research is needed, these tools may improve clinical management.
Read Full NewsA pooled analysis of 4 randomized trials found that more time with blood pressure below 130 mmHg after intracerebral hemorrhage reduced recurrent stroke risk.
The FDA set a first quarter 2027 goal date for troriluzole in spinocerebellar ataxia and plans an advisory committee after a 2025 complete response letter.
Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.
In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.
In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.
Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.
Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis
1.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
2.
Hypnotherapy may offer real benefits for cancer patient care
3.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer
4.
From Pathology to Precision: The Story of Leukemia Therapy
5.
Survivors of high-risk neuroblastoma face substantial late effects of modern therapies
1.
The Benefits of Understanding Haptoglobin High: What You Need to Know
2.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
3.
Immune Niches Supporting Tumor Resistance: Mechanisms, Clinical Implications, and Emerging Therapies
4.
Tumor Dormancy Dynamics and Recurrence-Free Survival Patterns
5.
Radiomics-Based Prediction of Treatment Response in Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation